Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance

References

• Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 40:499–507.
   PubMed Web of Science ®Google Scholar
• Chang CC. 2006. Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res. 8:103.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang S, et al. 2009. Oct4, a novel marker for human gastric cancer. J Surg Oncol. 99:414–419.
   PubMed Web of Science ®Google Scholar
• Du Y, Ma C, Wang Z, Liu Z, Liu H, Wang T. 2013. Nanog, a novel prognostic marker for lung cancer. Surg Oncol. 22:224–229.
   PubMed Web of Science ®Google Scholar
• Ezeh UI, Turek PJ, Reijo RA, Clark AT. 2005. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 104:2255–2265.
   PubMed Web of Science ®Google Scholar
• Gansler T, Ganz PA, Grant M, Greene FL, Johnstone P, Mahoney M, et al. 2010. Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin. 60:345–350.
   PubMed Web of Science ®Google Scholar
• Hattori N, Imao Y, Nishino K, Hattori N, Ohgane J, Yagi S, Tanaka S, Shiota K. 2007. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells. 12:387–396.
   PubMed Web of Science ®Google Scholar
• Hoei-Hansen CE, Sehested A, Juhler M, Lau YF, Skakkebaek NE, Laursen H, Rajpert-de Meyts E. 2006. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol. 209:25–33.
   PubMed Web of Science ®Google Scholar
• Huang Q, Wang AD, Dong J, Wang F, Sun JY, Lan Q. 2005. [Molecular researches on neural stem cell differentiation and malignant progression of ganglioglioma]. Tumor. 25:15–18.
   Google Scholar
• Kim SY, Kang JW, Song X, Kim BK, Yoo YD, Kwon YT, Lee YJ. 2013. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells. Cell Signal. 25:961–969.
   PubMed Web of Science ®Google Scholar
• Kruse C, Kajahn J, Petschnik AE, Maass A, Klink E, Rapoport DH, Wedel T. 2006. Adult pancreatic stem/progenitor cells spontaneously differentiate in vitro into multiple cell lineages and form teratoma-like structures. Ann Anat. 188:503–517.
   PubMed Web of Science ®Google Scholar
• Li XQ, Yang XL, Zhang G, Wu SP, Deng XB, Xiao SJ, et al. 2013. Nuclear beta-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer. J Transl Med. 11:114–125.
   PubMed Web of Science ®Google Scholar
• Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. 2005. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol. 7:165–171.
   PubMed Web of Science ®Google Scholar
• Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, et al. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:631–642.
   PubMed Web of Science ®Google Scholar
• Pan G, Li J, Zhou Y, Zheng H, Pei D. 2006. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 20:1730–1732.
   PubMed Web of Science ®Google Scholar
• Radzisheuskaya A, Silva JC. 2014. Do all roads lead to Oct4? The emerging concepts of induced pluripotency. Trends Cell Biol. 24:275–284.
   PubMed Web of Science ®Google Scholar
• Shi W, Wang H, Pan G, Geng Y, Guo Y, Pei D. 2006. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J Biol Chem 281:23319–23325.
   PubMed Web of Science ®Google Scholar
• Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. 2008. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol. 173:1165–1172.
   PubMed Web of Science ®Google Scholar
• Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. 2005. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 26:495–502.
   PubMed Web of Science ®Google Scholar
• Teng HF, Kuo YL, Loo MR, Li CL, Chu TW, Suo H, et al. 2010. Valproic acid enhances Oct4 promoter activity in myogenic cells. J Cell Biochem. 110:995–1004.
   PubMed Web of Science ®Google Scholar
• Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, et al. 2013. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 43:63–68.
   PubMed Web of Science ®Google Scholar
• You JS, Kang JK, Seo DW, Park JH, Park JW, Lee JC, et al. 2009. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression. Cancer Res. 69:5716–5725.
   PubMed Web of Science ®Google Scholar
• Yuan F, Zhou W, Zou C, Zhang Z, Hu H, Dai Z, Zhang Y. 2010. Expression of Oct4 in HCC and modulation to wnt/beta-catenin and TGF-beta signal pathways. Mol Cell Biochem. 343:155–162.
   PubMed Web of Science ®Google Scholar